A Combinatorial Biomarker for Infection Diagnosis in Children
- Conditions
- Respiratory Tract InfectionsFever
- Interventions
- Diagnostic Test: BV
- Registration Number
- NCT05971901
- Lead Sponsor
- Universität des Saarlandes
- Brief Summary
To describe the epidemiology, clinical presentation, diagnosis, therapy, and treatment outcomes of patients in whom the combination biomarker BV (combination of TRAIL, IP-10, and CRP) is used, and to compare them with control patients without BV measurement.
Secondary objectives:
* Qualitative evaluation of indication as well as adherence to the test result.
* Comparison of antimicrobial therapy, performed diagnostics, hospitalization, and outcomes between patients with high BV score (bacterial) and patients with low BV score (viral).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 770
- Suspicion of acute bacterial or viral infection
- Requirement of at least one BV test during medical presentation
- lack of informed consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description BV use cases BV cases in whom BV was ordered
- Primary Outcome Measures
Name Time Method Antibiotics up to 30 days Number of participants treated with antibiotics
- Secondary Outcome Measures
Name Time Method Hospitalization up to 30 days Number of participants admitted to the hospital
Antibiotic duration up to 30 days Length of antibiotic treatment per participant
Complications up to 30 days Rate of complications per participant
Tests up to 30 days Rate of ancillary tests per participant
Trial Locations
- Locations (4)
Saarland University
🇩🇪Homburg, Germany
Universitätsklinikum Bonn
🇩🇪Bonn, Germany
Sana Kliniken
🇩🇪Berlin, Germany
Universitätsklinikum Würzburg
🇩🇪Würzburg, Germany